5 Key Takeaways
-
1
Calcium channel blockers (CCBs) may increase the risk of progression to severe primary open-angle glaucoma (POAG), according to a large retrospective cohort study.
-
2
The study analyzed data from over 7,400 patients with mild to moderate POAG, comparing those using CCBs to matched controls.
-
3
Dihydropyridine CCBs (dCCBs) users had a 67% higher relative risk of progression to severe POAG compared to controls.
-
4
Nondihydropyridine CCBs (ndCCBs) users showed more than a threefold increased risk of progression to severe POAG.
-
5
The study authors noted that their findings do not establish causation and highlighted several limitations in their research.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
